How does 7814's pb Ratio compare to its peers?

Insufficient data to calculate 7814's Price-To-Book Ratio vs. peers for valuation analysis.

How does 7814's pb Ratio compare vs other companies in the TW Medical Equipment Industry?

Insufficient data to calculate 7814's Price-To-Book Ratio vs. industry for valuation analysis.

What is 7814's pb Ratio compared to its Fair pb Ratio? This is the expected pb Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate 7814's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of 7814 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate 7814's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

Horien Biochemical Technology (TPEX:7814) - Stock Price, News & Analysis

7814 Stock Overview

Operates as a supplier of cosmetic surgery raw materials and medical devices. More details

7814 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Shares are highly illiquid

Does not have a meaningful market cap (NT$1B)

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

My Notes

Capture your thoughts, links and company narrative

Horien Biochemical Technology Co., Ltd. Competitors

AViTA

TPEX:4735

NT$1.3b

Taiwan Biomaterial

TPEX:6649

NT$1.6b

Perfect Medical Industry

TPEX:6543

NT$1.7b

Unicon Optical

TPEX:4150

NT$1.7b

Price History & Performance

Summary of share price highs, lows and changes for Horien Biochemical Technology
Historical stock prices
Current Share Price	NT$33.35
52 Week High	NT$51.40
52 Week Low	NT$24.70
Beta	0
1 Month Change	11.35%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-24.20%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	7814	TW Medical Equipment	TW Market
7D	2.0%	6.3%	2.6%
1Y	n/a	-4.2%	23.3%

Return vs Industry: Insufficient data to determine how 7814 performed against the TW Medical Equipment industry.

Return vs Market: Insufficient data to determine how 7814 performed against the TW Market.

Price Volatility

Is 7814's price volatile compared to industry and market?
7814 volatility
7814 Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	4.0%
Market Average Movement	4.4%
10% most volatile stocks in TW Market	7.9%
10% least volatile stocks in TW Market	2.0%

Stable Share Price: 7814's share price has been volatile over the past 3 months compared to the TW market.

Volatility Over Time: Insufficient data to determine 7814's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2006	n/a	n/a	en.biohorien.com

Horien Biochemical Technology Co., Ltd. operates as a supplier of cosmetic surgery raw materials and medical devices. The company develops collagen-based materials used in cosmetic applications, providing products, such as collagen dental matrix, gunne-plug, and extracellular membrane. Horien Biochemical Technology Co., Ltd.

Horien Biochemical Technology Co., Ltd. Fundamentals Summary

How do Horien Biochemical Technology's earnings and revenue compare to its market cap?
7814 fundamental statistics
Market cap	NT$1.35b
Earnings (TTM)	NT$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is 7814 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
7814 income statement (TTM)
Revenue	NT$0
Cost of Revenue	NT$0
Gross Profit	NT$0
Other Expenses	NT$0
Earnings	NT$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did 7814 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/24 16:05
End of Day Share Price	2025/02/24 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Horien Biochemical Technology Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.